Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia.
Saved in:
| Title: | Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. |
|---|---|
| Authors: | Gloster, A. T., Wittchen, H. U., Einsle, F., Höfler, M., Lang, T., Helbig-Lang, S., Fydrich, T., Fehm, L., Hamm, A. O., Richter, J., Alpers, G. W., Gerlach, A. L., Ströhle, A., Kircher, T., Deckert, J., Zwanzger, P., Arolt, V. |
| Source: | European Archives of Psychiatry & Clinical Neuroscience. Nov2009 Supplement 2, Vol. 259, p155-166. 12p. 2 Diagrams, 4 Charts. |
| Subjects: | Panic disorders, Behavior therapy, Agoraphobia, Spatial behavior, Clinical trials, Therapeutics |
| Abstract: | Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated. [ABSTRACT FROM AUTHOR] |
| Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 44887749 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gloster%2C+A%2E+T%2E%22">Gloster, A. T.</searchLink><br /><searchLink fieldCode="AR" term="%22Wittchen%2C+H%2E+U%2E%22">Wittchen, H. U.</searchLink><br /><searchLink fieldCode="AR" term="%22Einsle%2C+F%2E%22">Einsle, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Höfler%2C+M%2E%22">Höfler, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Lang%2C+T%2E%22">Lang, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Helbig-Lang%2C+S%2E%22">Helbig-Lang, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Fydrich%2C+T%2E%22">Fydrich, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Fehm%2C+L%2E%22">Fehm, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Hamm%2C+A%2E+O%2E%22">Hamm, A. O.</searchLink><br /><searchLink fieldCode="AR" term="%22Richter%2C+J%2E%22">Richter, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Alpers%2C+G%2E+W%2E%22">Alpers, G. W.</searchLink><br /><searchLink fieldCode="AR" term="%22Gerlach%2C+A%2E+L%2E%22">Gerlach, A. L.</searchLink><br /><searchLink fieldCode="AR" term="%22Ströhle%2C+A%2E%22">Ströhle, A.</searchLink><br /><searchLink fieldCode="AR" term="%22Kircher%2C+T%2E%22">Kircher, T.</searchLink><br /><searchLink fieldCode="AR" term="%22Deckert%2C+J%2E%22">Deckert, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Zwanzger%2C+P%2E%22">Zwanzger, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Arolt%2C+V%2E%22">Arolt, V.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Nov2009 Supplement 2, Vol. 259, p155-166. 12p. 2 Diagrams, 4 Charts. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Panic+disorders%22">Panic disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Behavior+therapy%22">Behavior therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Agoraphobia%22">Agoraphobia</searchLink><br /><searchLink fieldCode="DE" term="%22Spatial+behavior%22">Spatial behavior</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Cognitive behavioral therapy (CBT) is efficacious for panic disorder with agoraphobia (PD/A). Nevertheless, the active ingredients of treatment and the mechanisms through which CBT achieves its effects remain largely unknown. The mechanisms of action in CBT (MAC) study was established to investigate these questions in 369 patients diagnosed with PD/A. The MAC study utilized a multi-center, randomized controlled design, with two active treatment conditions in which the administration of exposure was varied, and a wait-list control group. The special feature of MAC is the way in which imbedded experimental, psychophysiological, and neurobiological paradigms were included to elucidate therapeutic and psychopathological processes. This paper describes the aims and goals of the MAC study and the methods utilized to achieve them. All aspects of the research design (e.g., assessments, treatment, experimental procedures) were implemented so as to facilitate the detection of active therapeutic components, and the mediators and moderators of therapeutic change. To this end, clinical, behavioral, physiological, experimental, and genetic data were collected and will be integrated. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=44887749 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00406-009-0065-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 155 Subjects: – SubjectFull: Panic disorders Type: general – SubjectFull: Behavior therapy Type: general – SubjectFull: Agoraphobia Type: general – SubjectFull: Spatial behavior Type: general – SubjectFull: Clinical trials Type: general – SubjectFull: Therapeutics Type: general Titles: – TitleFull: Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gloster, A. T. – PersonEntity: Name: NameFull: Wittchen, H. U. – PersonEntity: Name: NameFull: Einsle, F. – PersonEntity: Name: NameFull: Höfler, M. – PersonEntity: Name: NameFull: Lang, T. – PersonEntity: Name: NameFull: Helbig-Lang, S. – PersonEntity: Name: NameFull: Fydrich, T. – PersonEntity: Name: NameFull: Fehm, L. – PersonEntity: Name: NameFull: Hamm, A. O. – PersonEntity: Name: NameFull: Richter, J. – PersonEntity: Name: NameFull: Alpers, G. W. – PersonEntity: Name: NameFull: Gerlach, A. L. – PersonEntity: Name: NameFull: Ströhle, A. – PersonEntity: Name: NameFull: Kircher, T. – PersonEntity: Name: NameFull: Deckert, J. – PersonEntity: Name: NameFull: Zwanzger, P. – PersonEntity: Name: NameFull: Arolt, V. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 11 Text: Nov2009 Supplement 2 Type: published Y: 2009 Identifiers: – Type: issn-print Value: 09401334 Numbering: – Type: volume Value: 259 Titles: – TitleFull: European Archives of Psychiatry & Clinical Neuroscience Type: main |
| ResultId | 1 |